The Hepatitis B Virus X Protein Inhibits Thymine DNA Glycosylase Initiated Base Excision Repair

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  van de Klundert, Maarten A A ^a,b   van Hemert, Formijn J ^b   Zaaijer, Hans L ^a,c   Kootstra, Neeltje A ^b  

^a Center for Infection and Immunity Amsterdam CINIMA   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VIRUS X PROTEIN; THYMINE DNA GLYCOSYLASE; VIRUS DNA; TRANSACTIVATOR PROTEIN;

ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; ENZYME INHIBITION; EXCISION REPAIR; HEPATITIS B VIRUS; NONHUMAN; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SITE DIRECTED MUTAGENESIS; STRUCTURAL HOMOLOGY; VIRUS REPLICATION; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; DNA REPAIR; DNA REPLICATION; GENETICS; HEK293 CELL LINE; HEPATITIS B; HEPG2 CELL LINE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; VIROLOGY;

HEPATITIS B VIRUS;

CARCINOMA, HEPATOCELLULAR; DNA REPAIR; DNA REPLICATION; HEK293 CELLS; HEP G2 CELLS; HEPATITIS B; HUMANS; LIVER NEOPLASMS; THYMINE DNA GLYCOSYLASE; TRANS-ACTIVATORS;

EID: 84869066771     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048940     Document Type: Article

References (39)

1. Kew MC, (2011) Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma. J Gastroenterol Hepatol 26Suppl 1: 144-152.
2. Neuveut C, Wei Y, Buendia MA, (2010) Mechanisms of HBV-related hepatocarcinogenesis. J Hepatol 52: 594-604.
3. Liu XH, Lin J, Zhang SH, Zhang SM, Feitelson MA, et al. (2008) COOH-terminal deletion of HBx gene is a frequent event in HBV-associated hepatocellular carcinoma. World J Gastroenterol 14: 1346-1352.
4. Kim CM, Koike K, Saito I, Miyamura T, Jay G, (1991) HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351: 317-320.
5. Zhu H, Wang Y, Chen J, Cheng G, Xue J, (2004) Transgenic mice expressing hepatitis B virus X protein are more susceptible to carcinogen induced hepatocarcinogenesis. Exp Mol Pathol 76: 44-50.
6. Jia L, Wang XW, Harris CC, (1999) Hepatitis B virus X protein inhibits nucleotide excision repair. Int J Cancer 80: 875-879.
7. Qadri I, Fatima K, AbdeL-Hafiz H, (2011) Hepatitis B virus X protein impedes the DNA repair via its association with transcription factor, TFIIH. BMC Microbiol 11: 48.
8. Mathonnet G, Lachance S, Alaoui-Jamali M, Drobetsky EA, (2004) Expression of hepatitis B virus X oncoprotein inhibits transcription-coupled nucleotide excision repair in human cells. Mutat Res 554: 305-318.
9. Levrero M, Pollicino T, Petersen J, Belloni L, Raimondo G, et al. (2009) Control of cccDNA function in hepatitis B virus infection. J Hepatol 51: 581-592.
10. Kim K, Kim KH, Kim HH, Cheong J, (2008) Hepatitis B virus X protein induces lipogenic transcription factor SREBP1 and fatty acid synthase through the activation of nuclear receptor LXRalpha. Biochem J 416: 219-230.
11. Kong HJ, Hong SH, Lee MY, Kim HD, Lee JW, et al. (2000) Direct binding of hepatitis B virus X protein and retinoid X receptor contributes to phosphoenolpyruvate carboxykinase gene transactivation. FEBS Lett 483: 114-118.
12. Zheng Y, Chen WL, Ma WL, Chang C, Ou JH, (2007) Enhancement of gene transactivation activity of androgen receptor by hepatitis B virus X protein. Virology 363: 454-461.
13. Lee TH, Elledge SJ, Butel JS, (1995) Hepatitis B virus X protein interacts with a probable cellular DNA repair protein. J Virol 69: 1107-1114.
14. Li T, Robert EI, van Breugel PC, Strubin M, Zheng N, (2010) A promiscuous alpha-helical motif anchors viral hijackers and substrate receptors to the CUL4-DDB1 ubiquitin ligase machinery. Nat Struct Mol Biol 17: 105-111.
15. Sitterlin D, Lee TH, Prigent S, Tiollais P, Butel JS, et al. (1997) Interaction of the UV-damaged DNA-binding protein with hepatitis B virus X protein is conserved among mammalian hepadnaviruses and restricted to transactivation-proficient X-insertion mutants. J Virol 71: 6194-6199.
16. Wentz MJ, Becker SA, Slagle BL, (2000) Dissociation of DDB1-binding and transactivation properties of the hepatitis B virus X protein. Virus Res 68: 87-92.
17. Leupin O, Bontron S, Schaeffer C, Strubin M, (2005) Hepatitis B virus X protein stimulates viral genome replication via a DDB1-dependent pathway distinct from that leading to cell death. J Virol 79: 4238-4245.
18. Hodgson AJ, Hyser JM, Keasler VV, Cang Y, Slagle BL, (2012) Hepatitis B virus regulatory HBx protein binding to DDB1 is required but is not sufficient for maximal HBV replication. Virology 426: 73-82.
19. Sitterlin D, Bergametti F, Tiollais P, Tennant BC, Transy C, (2000) Correct binding of viral X protein to UVDDB-p127 cellular protein is critical for efficient infection by hepatitis B viruses. Oncogene 19: 4427-4431.
20. van Hemert FJ, van de Klundert MA, Lukashov VV, Kootstra NA, Berkhout B, et al. (2011) Protein X of hepatitis B virus: origin and structure similarity with the central domain of DNA glycosylase. PLoS One 6: e23392.
21. Cortazar D, Kunz C, Saito Y, Steinacher R, Schar P, (2007) The enigmatic thymine DNA glycosylase. DNA Repair (Amst) 6: 489-504.
22. Baumert TF, Rogers SA, Hasegawa K, Liang TJ, (1996) Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication. J Clin Invest 98: 2268-2276.
23. Baumert TF, Marrone A, Vergalla J, Liang TJ, (1998) Naturally occurring mutations define a novel function of the hepatitis B virus core promoter in core protein expression. J Virol 72: 6785-6795.
24. Li S, Huang Q, Wang L, Lan Y, Zhang X, et al. (2010) A convenient spectrometric assay system for intracellular quantitative measurement of DNA glycosylase activity. Acta Biochim Biophys Sin (Shanghai) 42: 381-387.
25. Keasler VV, Hodgson AJ, Madden CR, Slagle BL, (2007) Enhancement of hepatitis B virus replication by the regulatory X protein in vitro and in vivo. J Virol 81: 2656-2662.
26. Visnes T, Akbari M, Hagen L, Slupphaug G, Krokan HE, (2008) The rate of base excision repair of uracil is controlled by the initiating glycosylase. DNA Repair (Amst) 7: 1869-1881.
27. Fitzgerald ME, Drohat AC, (2008) Coordinating the initial steps of base excision repair. Apurinic/apyrimidinic endonuclease 1 actively stimulates thymine DNA glycosylase by disrupting the product complex. J Biol Chem 283: 32680-32690.
28. Murakami S, Cheong JH, Kaneko S, (1994) Human hepatitis virus X gene encodes a regulatory domain that represses transactivation of X protein. J Biol Chem 269: 15118-15123.
29. Maiti A, Morgan MT, Pozharski E, Drohat AC, (2008) Crystal structure of human thymine DNA glycosylase bound to DNA elucidates sequence-specific mismatch recognition. Proc Natl Acad Sci U S A 105: 8890-8895.
30. van de Klundert MA, Cremer J, Kootstra NA, Boot HJ, Zaaijer HL, (2012) Comparison of the hepatitis B virus core, surface and polymerase gene substitution rates in chronically infected patients. J Viral Hepat 19: e34-e40.
31. Zaaijer HL, Bouter S, Boot HJ, (2008) Substitution rate of the hepatitis B virus surface gene. J Viral Hepat 15: 239-245.
32. Hsu C, Cheng JC, Cheng AL, (2004) Recent advances in non-surgical treatment for advanced hepatocellular carcinoma. J Formos Med Assoc 103: 483-495.
33. Kunz C, Focke F, Saito Y, Schuermann D, Lettieri T, et al. (2009) Base excision by thymine DNA glycosylase mediates DNA-directed cytotoxicity of 5-fluorouracil. PLoS Biol 7: e91.
34. Chung C, Park SG, Park YM, Joh JW, Jung G, (2007) Interferon-gamma sensitizes hepatitis B virus-expressing hepatocarcinoma cells to 5-fluorouracil through inhibition of hepatitis B virus-mediated nuclear factor-kappaB activation. Cancer Sci 98: 1758-1766.
35. He Y, Sun HQ, He XE, Wang WL, Lei JH, (2010) Knockdown of HBx by RNAi inhibits proliferation and enhances chemotherapy-induced apoptosis in hepatocellular carcinoma cells. Med Oncol 27: 1227-1233.
36. Liu Y, Lou G, Wu W, Zheng M, Shi Y, et al. (2011) Involvement of the NF-kappaB pathway in multidrug resistance induced by HBx in a hepatoma cell line. J Viral Hepat 18: e439-e446.
37. Evens AM, Jovanovic BD, Su YC, Raisch DW, Ganger D, et al. (2011) Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports. Ann Oncol 22: 1170-1180.
38. Manzano-Alonso ML, Castellano-Tortajada G, (2011) Reactivation of hepatitis B virus infection after cytotoxic chemotherapy or immunosuppressive therapy. World J Gastroenterol 17: 1531-1537.
39. Hsu CH, Hsu HC, Chen HL, Gao M, Yeh PY, et al. (2004) Doxorubicin activates hepatitis B virus (HBV) replication in HBV-harboring hepatoblastoma cells. A possible novel mechanism of HBV reactivation in HBV carriers receiving systemic chemotherapy. Anticancer Res 24: 3035-3040.